Biophotonics Market to reach $107.2 billion by 2035

Biophotonics market was valued at $52.9 billion in 2025 and is projected to reach $107.2 billion by 2035, growing at a CAGR of 7.4% during the forecast period (2026-2035). The increasing prevalence of chronic diseases is a primary factor supporting the expansion of biophotonics-based diagnostic solutions. According to the World Health Organization, noncommunicable diseases account for nearly 74% of global deaths, highlighting the growing need for early and accurate detection systems. Optical imaging and spectroscopy-based tools are gaining traction due to their ability to provide non-invasive and real-time diagnosis, particularly in oncology and cardiovascular applications. In addition, data from the National Cancer Institute indicates a continued rise in cancer incidence, further reinforcing the need for advanced screening technologies. Biophotonics systems enable high-resolution tissue characterization, improving diagnostic confidence and reducing dependency on invasive procedures. These capabilities are aligning with healthcare priorities focused on early intervention and improved patient outcomes. As a result, demand for photonics-based diagnostic instruments is increasing across hospitals and specialized laboratories. The growing clinical acceptance of minimally invasive diagnostics continues to strengthen the commercial adoption of biophotonics products.

Browse the full report description of “Biophotonics Market Size, Share & Trends Analysis Report by Technology (In-Vitro, In-Vivo), by Application (Medical Diagnostics, Therapeutics (e.g., laser-based treatments), Biosensing & Bioimaging, Drug Discovery & Development, Agriculture & Food Testing, Environmental Monitoring, Forensic Science, and Others), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/biophotonics-market

Innovation Leaders Transforming the Biophotonics Market

The key players in the biophotonics market include Thermo Fisher Scientific Inc., Carl Zeiss Meditec AG, Hamamatsu Photonics K.K., Olympus Corporation, Leica Microsystems GmbH, among others.

• In May 2025, ZEISS partnered with Alpenglow Biosciences to develop an inverted light-sheet microscope and bioinformatics pipeline for clinical use.

• In April 2025, Hamamatsu Photonics and Sirona Dx announced a strategic partnership to expand access to biophotonics technology programs.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Technology
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Thermo Fisher Scientific Inc., Carl Zeiss Meditec AG, Hamamatsu Photonics K.K., Olympus Corporation, Leica Microsystems GmbH, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biophotonics Market Report Segment

By Technology

• In-Vitro
• In-Vivo

By Application

• Medical Diagnostics
• Therapeutics
• Biosensing & Bioimaging
• Drug Discovery & Development
• Agriculture & Food Testing
• Environmental Monitoring
• Forensic Science
• Others

Global Biophotonics Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biophotonics-market